Blootstelling hormoonontregelende stoffen kost EU >€150 mld

A new economic analysis found exposure to endocrine-disrupting chemicals likely costs the European Union €157 billion ($209 billion) a year in actual health care expenses and lost earning potential.
A new series of studies has been published in the Endocrine Society’s Journal of Clinical Endocrinology and Metabolism.
Global experts in this field concluded that infertility and male reproductive dysfunctions, birth defects, obesity, diabetes, cardiovascular disease, and neurobehavioral and learning disorders were among the conditions than can be attributed in part to exposure to endocrine-disrupting chemicals (Persbericht Endocrine Society, 5 maart 2015).
Klik hier voor het volledige persbericht.
Klik hier voor meer informatie over de NVC Workshop Wetgeving Voedselcontactmaterialen.
Klik hier voor meer informatie over de online NVC E-Workshop Food Contact Materials Legislation.

Heeft u vragen over dit onderwerp, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411. Dit bericht is ook opgenomen in ons maandelijkse overzicht, de NVC Members-only Update.